23Jan
Blog: Cooley's 2019 Life Sciences M&A Year in Review
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By:
Cooley LLP
Related
Letters of intent, or LOIs, serve an important purpose in corporate deals and M&A, and their use is ...
Read More >
As coronavirus (COVID-19) continues to disrupt lives and businesses, it is important to consider how...
Read More >
Whistleblowing can and should be an essential tool for organisations who want to deliver effective c...
Read More >
On Jan. 1, 2020, the California Consumer Privacy Act (CCPA), a consumer-friendly privacy law inspire...
Read More >
Welcome to the 2019 edition of the Meritas Legal Guide for Business Investment and Expansion in Aust...
Read More >
In today's Part 2 of 2 of my back-from-summer-hiatus series, I am joined by L&E attorney Sarah Kelly...
Read More >